Dydrogesterone Drug Market Revenue 2024 to 2034
Dydrogesterone Drug Market Revenue 2024 to 2034
The dydrogesterone drug market, valued at USD 0.79 billion in 2024, will expand to USD 1.96 billion by 2034, growing at 9.54% CAGR, driven by fertility treatments and hormonal disorder management.
Report ID: 10458
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 0.79 Bn
Forecast Year,
USD 1.96 Bn
CAGR, 2025 -
9.54%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Dydrogesterone Drug Market Size Analysis
Dydrogesterone Drug Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dysmenorrhea | 0.05 | 0.04 | 0.04 | 0.05 | 0.04 | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 | 0.02 |
| Endometriosis | 0.35 | 0.39 | 0.43 | 0.50 | 0.57 | 0.63 | 0.72 | 0.78 | 0.84 | 0.95 | 1.00 |
| Infertility/Luteal Support | 0.22 | 0.23 | 0.27 | 0.29 | 0.34 | 0.38 | 0.42 | 0.48 | 0.51 | 0.57 | 0.66 |
| Other Gynecological | 0.17 | 0.20 | 0.21 | 0.20 | 0.20 | 0.22 | 0.21 | 0.22 | 0.25 | 0.24 | 0.28 |
Dydrogesterone Drug Market Size By Dosage Form 2024 to 2034 (USD )
| Dosage Form | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tablets | 0.41 | 0.47 | 0.52 | 0.59 | 0.67 | 0.71 | 0.81 | 0.94 | 1.02 | 1.18 | 1.27 |
| Injectables | 0.31 | 0.33 | 0.36 | 0.40 | 0.41 | 0.43 | 0.43 | 0.47 | 0.51 | 0.53 | 0.58 |
| Other Forms | 0.08 | 0.06 | 0.07 | 0.06 | 0.06 | 0.10 | 0.12 | 0.08 | 0.12 | 0.09 | 0.12 |
Dydrogesterone Drug Market Size By Distribution 2024 to 2034 (USD )
| Distribution | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 0.33 | 0.38 | 0.40 | 0.45 | 0.50 | 0.56 | 0.60 | 0.67 | 0.74 | 0.87 | 0.92 |
| Retail Pharmacies | 0.15 | 0.14 | 0.17 | 0.20 | 0.23 | 0.26 | 0.28 | 0.33 | 0.38 | 0.37 | 0.40 |
| Online | 0.30 | 0.34 | 0.38 | 0.39 | 0.41 | 0.43 | 0.48 | 0.49 | 0.51 | 0.56 | 0.65 |
Dydrogesterone Drug Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.24 | 0.28 | 0.32 | 0.34 | 0.37 | 0.40 | 0.44 | 0.48 | 0.52 | 0.59 | 0.67 |
| Europe | 0.13 | 0.15 | 0.17 | 0.21 | 0.22 | 0.26 | 0.29 | 0.29 | 0.37 | 0.38 | 0.37 |
| Asia Pacific | 0.22 | 0.23 | 0.24 | 0.25 | 0.27 | 0.30 | 0.31 | 0.35 | 0.36 | 0.42 | 0.47 |
| Latin America | 0.08 | 0.07 | 0.08 | 0.11 | 0.11 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.12 |
| Middle East & Africa | 0.12 | 0.13 | 0.13 | 0.13 | 0.18 | 0.19 | 0.23 | 0.28 | 0.30 | 0.32 | 0.34 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
